Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patientsThomas Kuntzen, Todd M. Allen, Jörg Timm et al.|Hepatology|2008Cited by 345
Clonal expansion and activation of tissue-resident memory-like T <sub>H</sub> 17 cells expressing GM-CSF in the lungs of patients with severe COVID-19Yu Zhao, Christian F. Krebs, Hans‐Joachim Paust et al.|Science Immunology|2021Cited by 174
New findings in HCV genotype distribution in selected West European, Russian and Israeli regionsVladimir Kartashev, Orna Mor, Matthias Döring et al.|Journal of Clinical Virology|2016Cited by 73
Respiratory muscle dysfunction in long-COVID patientsJan K. Hennigs, Hans Klose, Marie Huwe et al.|Infection|2022Cited by 52
LB01 SIX WEEKS OF SOFOSBUVIR/LEDIPASVIR TREATMENT OF ACUTE HEPATITIS C VIRUS GENOTYPE 1 MONOINFECTION: FINAL RESULTS OF THE THE GERMAN HEPNET ACUTE HCV IV STUDYKatja Deterding, Maurizio Degiuli, Christoph D. Spinner et al.|United European Gastroenterology Journal|2016Cited by 5